Medical Device News Magazine

ColdVentures Unveils First-of-its-Kind, Class 1 FDA Medical Device ColdVest to Prevent Heat-Related Deaths

Portable Vest Protects Military Personnel, Outdoor Workers, Athletes, Students and More Without Requiring Electricity or Refrigeration Created for Rapid Emergency Cooling Before EMS Arrival

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

With annual heat-related deaths projected to increase 370 percent by 2050, rising temperatures and extreme heat events pose a significant threat to humans. As heat waves intensify, ColdVentures, a medical device company developing innovative new technologies to combat heat-related deaths, has unveiled ColdVest, a first-of-its-kind, Class 1 FDA portable emergency cooling device to protect people from heat-related brain or organ damage and death before emergency medical services arrive.

“Heat-related deaths have been increasing dramatically in recent years, with estimates ranging from tens of thousands to hundreds of thousands of incidents annually worldwide. 2023 alone set a heat death record in the United States. We need to look beyond      treatment methods like ice baths and adopt new technologies to save lives, as heat stroke is preventable in most cases,” said Tracie Wagman, ColdVentures Co-Founder and CEO. “ColdVest is the only portable emergency device available for heat stroke that does not require electricity or refrigeration. Given that people endured, on average, 86 days of health-threatening high temperatures last year globally, ColdVest has the potential to save thousands of lives around the globe each year.”

Heat stroke poses a particularly deadly threat to military personnel performing strenuous activities and wearing heavy gear in scorching environments; outdoor workers including construction crews, farmers and landscapers who are exposed to direct sunlight and high temperatures for long hours; firefighters battling blazes; and athletes training and competing in hot weather conditions. Heat stroke is especially dangerous for young athletes or those unaccustomed to extreme temperatures.

People suffering from heat stroke typically have 30 minutes before suffering permanent harm. In just under three minutes, ColdVest can reduce core body temperatures up to five degrees and stabilize an individual. Using patented endothermic cooling technology, ColdVest does not require electricity, refrigeration, ice or special storage. To use, add three liters of liquid to ColdVest’s integrated bladder, which then spreads throughout the vest to rapidly activate internal cooling chemicals. ColdVest is then placed over the torso of an individual for immediate relief. To learn more, visit

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”